These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20429692

  • 1. Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.
    Viigimaa M, Abina J, Zemtsovskaya G, Tikhaze A, Konovalova G, Kumskova E, Lankin V.
    Blood Press; 2010 Jun; 19(3):164-8. PubMed ID: 20429692
    [Abstract] [Full Text] [Related]

  • 2. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP, Zhou X.
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [Abstract] [Full Text] [Related]

  • 3. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T, Martin-Nizard F, Kandoussi A, Kyndt X, Vanhille P, Hachulla E, Hatron PY, Fruchart JC, Duriez P, Lambert M.
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [Abstract] [Full Text] [Related]

  • 4. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G.
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A, Young IS, Wisdom GB.
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [Abstract] [Full Text] [Related]

  • 6. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
    Pawlak K, Mysliwiec M, Pawlak D.
    Life Sci; 2013 Mar 12; 92(4-5):253-8. PubMed ID: 23295961
    [Abstract] [Full Text] [Related]

  • 7. Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infarction.
    Kametsu Y, Kitagawa Y, Sekiyama S, Takagi S.
    Tokai J Exp Clin Med; 2005 Sep 12; 30(3):171-6. PubMed ID: 16285608
    [Abstract] [Full Text] [Related]

  • 8. [Indicators of oxidative stress in cardiovascular diseases. I. Lipoperoxidation].
    Racek J, Holecek V, Trefil L.
    Vnitr Lek; 1999 Jun 12; 45(6):367-72. PubMed ID: 11045174
    [Abstract] [Full Text] [Related]

  • 9. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB.
    Clin Endocrinol (Oxf); 2009 Mar 12; 70(3):469-74. PubMed ID: 18727709
    [Abstract] [Full Text] [Related]

  • 10. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 11. Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia.
    Makedou KG, Mikhailidis DP, Makedou A, Iliadis S, Kourtis A, Vavatsi-Christaki N, Papageorgiou GE.
    Angiology; 2009 Jun 09; 60(4):455-61. PubMed ID: 19648144
    [Abstract] [Full Text] [Related]

  • 12. Concentration of malondialdehyde-modified low-density lipoprotein in the jugular bulb during carotid endarterectomy correlates with development of postoperative cognitive impairment.
    Saito H, Ogasawara K, Komoribayashi N, Kobayashi M, Inoue T, Otawara Y, Ogawa A.
    Neurosurgery; 2007 Jun 09; 60(6):1067-73; discussion 1073-4. PubMed ID: 17538381
    [Abstract] [Full Text] [Related]

  • 13. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 14. Pedometer step counts and oxidized low-density lipoprotein levels among asymptomatic subjects.
    Kotani K, Taniguchi N.
    Ann Clin Lab Sci; 2012 Apr 01; 42(4):435-8. PubMed ID: 23090743
    [Abstract] [Full Text] [Related]

  • 15. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX, Li P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep 01; 35(5):690-2. PubMed ID: 15460421
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV, Kaplun VV, Dvoryantsev SN, Orekhov AN.
    Biochem Biophys Res Commun; 1995 Sep 14; 214(2):608-13. PubMed ID: 7677772
    [Abstract] [Full Text] [Related]

  • 17. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z, Mrzljak V, Turk N, Metelko Z.
    Diabetes Nutr Metab; 1999 Dec 14; 12(6):413-7. PubMed ID: 10782563
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A, Hennuyer N, Tailleux A, Furman C, Duverger N, Caillaud JM, Castro G, Fievet C, Fruchart JC, Duriez P.
    Clin Sci (Lond); 2001 Mar 14; 100(3):343-55. PubMed ID: 11222122
    [Abstract] [Full Text] [Related]

  • 19. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia.
    Pirinccioglu AG, Gökalp D, Pirinccioglu M, Kizil G, Kizil M.
    Clin Biochem; 2010 Oct 14; 43(15):1220-4. PubMed ID: 20691171
    [Abstract] [Full Text] [Related]

  • 20. Streptococcus thermophilus fermented milk reduces serum MDA-LDL and blood pressure in healthy and mildly hypercholesterolaemic adults.
    Ito M, Kusuhara S, Yokoi W, Sato T, Ishiki H, Miida S, Matsui A, Nakamori K, Nonaka C, Miyazaki K.
    Benef Microbes; 2017 Apr 26; 8(2):171-178. PubMed ID: 28299944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.